ZA200100330B

ZA200100330B - Neurotrophic growth factor.

Neurotrophic growth factor. Download PDF

Info

Publication number: ZA200100330B
Authority: ZA; South Africa
Prior art keywords: growth factor; enovin; nucleic acid; disease; sequence
Prior art date: 1998-07-14

Application number

ZA200100330A

Other languages

English (en)

Inventor

Hugo Alfonso Geerts

Theo Frans Meert

Luc August Laurentius Ve Donck

Stefan Leo Jozef Masure

Miroslav Cik

Original Assignee

Janssen Pharmaceutica Nv

Priority date

1998-07-14

Filing date

2001-01-11

Publication date

2002-01-11

2001-01-11 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2002-01-11 Publication of ZA200100330B publication Critical patent/ZA200100330B/en

Links

239000003102 growth factor Substances 0.000 title claims description 68
230000000508 neurotrophic effect Effects 0.000 title claims description 36
102100026376 Artemin Human genes 0.000 claims description 211
108010059258 enovin Proteins 0.000 claims description 199
150000007523 nucleic acids Chemical class 0.000 claims description 64
108020004707 nucleic acids Proteins 0.000 claims description 56
102000039446 nucleic acids Human genes 0.000 claims description 56
239000002299 complementary DNA Substances 0.000 claims description 50
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 50
238000000034 method Methods 0.000 claims description 50
150000001875 compounds Chemical class 0.000 claims description 42
230000014509 gene expression Effects 0.000 claims description 37
108020004414 DNA Proteins 0.000 claims description 35
208000035475 disorder Diseases 0.000 claims description 35
108091028043 Nucleic acid sequence Proteins 0.000 claims description 27
230000027455 binding Effects 0.000 claims description 24
125000003275 alpha amino acid group Chemical group 0.000 claims description 23
239000000556 agonist Substances 0.000 claims description 21
239000013598 vector Substances 0.000 claims description 21
239000005557 antagonist Substances 0.000 claims description 20
230000001537 neural effect Effects 0.000 claims description 20
230000000694 effects Effects 0.000 claims description 19
208000002551 irritable bowel syndrome Diseases 0.000 claims description 18
238000011282 treatment Methods 0.000 claims description 18
208000014674 injury Diseases 0.000 claims description 16
201000010099 disease Diseases 0.000 claims description 15
238000004519 manufacturing process Methods 0.000 claims description 15
239000003814 drug Substances 0.000 claims description 14
239000008194 pharmaceutical composition Substances 0.000 claims description 13
230000000692 anti-sense effect Effects 0.000 claims description 12
239000013604 expression vector Substances 0.000 claims description 12
230000004913 activation Effects 0.000 claims description 11
230000002093 peripheral effect Effects 0.000 claims description 11
239000013612 plasmid Substances 0.000 claims description 11
102000004196 processed proteins & peptides Human genes 0.000 claims description 11
108090000765 processed proteins & peptides Proteins 0.000 claims description 11
208000002193 Pain Diseases 0.000 claims description 10
208000018737 Parkinson disease Diseases 0.000 claims description 10
201000006417 multiple sclerosis Diseases 0.000 claims description 10
208000033808 peripheral neuropathy Diseases 0.000 claims description 10
229920001184 polypeptide Polymers 0.000 claims description 10
208000024827 Alzheimer disease Diseases 0.000 claims description 9
206010010539 Congenital megacolon Diseases 0.000 claims description 9
208000004592 Hirschsprung disease Diseases 0.000 claims description 9
206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 9
239000003937 drug carrier Substances 0.000 claims description 9
230000012010 growth Effects 0.000 claims description 9
230000001404 mediated effect Effects 0.000 claims description 9
239000000546 pharmaceutical excipient Substances 0.000 claims description 9
206010012735 Diarrhoea Diseases 0.000 claims description 8
108091000080 Phosphotransferase Proteins 0.000 claims description 8
208000025747 Rheumatic disease Diseases 0.000 claims description 8
208000027418 Wounds and injury Diseases 0.000 claims description 8
230000006378 damage Effects 0.000 claims description 8
230000001965 increasing effect Effects 0.000 claims description 8
230000001272 neurogenic effect Effects 0.000 claims description 8
239000002581 neurotoxin Substances 0.000 claims description 8
231100000618 neurotoxin Toxicity 0.000 claims description 8
102000020233 phosphotransferase Human genes 0.000 claims description 8
230000011664 signaling Effects 0.000 claims description 8
208000011580 syndromic disease Diseases 0.000 claims description 8
230000008733 trauma Effects 0.000 claims description 8
208000006011 Stroke Diseases 0.000 claims description 7
208000029028 brain injury Diseases 0.000 claims description 7
239000003085 diluting agent Substances 0.000 claims description 7
208000027866 inflammatory disease Diseases 0.000 claims description 7
210000000578 peripheral nerve Anatomy 0.000 claims description 7
230000000552 rheumatic effect Effects 0.000 claims description 7
208000010859 Creutzfeldt-Jakob disease Diseases 0.000 claims description 6
206010021518 Impaired gastric emptying Diseases 0.000 claims description 6
208000014675 Prion-associated disease Diseases 0.000 claims description 6
108700019146 Transgenes Proteins 0.000 claims description 6
206010047700 Vomiting Diseases 0.000 claims description 6
230000002496 gastric effect Effects 0.000 claims description 6
206010051747 multiple endocrine neoplasia Diseases 0.000 claims description 6
206010061311 nervous system neoplasm Diseases 0.000 claims description 6
206010017943 Gastrointestinal conditions Diseases 0.000 claims description 5
206010020751 Hypersensitivity Diseases 0.000 claims description 5
208000026935 allergic disease Diseases 0.000 claims description 5
230000009610 hypersensitivity Effects 0.000 claims description 5
230000000968 intestinal effect Effects 0.000 claims description 5
108010040003 polyglutamine Proteins 0.000 claims description 5
229920000155 polyglutamine Polymers 0.000 claims description 5
230000009261 transgenic effect Effects 0.000 claims description 5
101150089783 Gfral gene Proteins 0.000 claims description 4
206010021333 Ileus paralytic Diseases 0.000 claims description 4
206010028980 Neoplasm Diseases 0.000 claims description 4
230000001580 bacterial effect Effects 0.000 claims description 4
229940079593 drug Drugs 0.000 claims description 4
230000001771 impaired effect Effects 0.000 claims description 4
230000019491 signal transduction Effects 0.000 claims description 4
206010010774 Constipation Diseases 0.000 claims description 3
102000053602 DNA Human genes 0.000 claims description 3
208000018522 Gastrointestinal disease Diseases 0.000 claims description 3
206010052105 Gastrointestinal hypomotility Diseases 0.000 claims description 3
201000005081 Intestinal Pseudo-Obstruction Diseases 0.000 claims description 3
206010054048 Postoperative ileus Diseases 0.000 claims description 3
230000003247 decreasing effect Effects 0.000 claims description 3
230000003111 delayed effect Effects 0.000 claims description 3
201000006549 dyspepsia Diseases 0.000 claims description 3
208000001288 gastroparesis Diseases 0.000 claims description 3
230000002779 inactivation Effects 0.000 claims description 3
230000033001 locomotion Effects 0.000 claims description 3
230000002572 peristaltic effect Effects 0.000 claims description 3
210000000813 small intestine Anatomy 0.000 claims description 3
102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 claims description 2
108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 claims description 2
101000634196 Homo sapiens Neurotrophin-3 Proteins 0.000 claims description 2
101000579425 Homo sapiens Proto-oncogene tyrosine-protein kinase receptor Ret Proteins 0.000 claims description 2
101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 claims description 2
108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 claims description 2
102000019145 JUN kinase activity proteins Human genes 0.000 claims description 2
108091054455 MAP kinase family Proteins 0.000 claims description 2
102000043136 MAP kinase family Human genes 0.000 claims description 2
102100028286 Proto-oncogene tyrosine-protein kinase receptor Ret Human genes 0.000 claims description 2
102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 claims description 2
102100023132 Transcription factor Jun Human genes 0.000 claims description 2
229940127089 cytotoxic agent Drugs 0.000 claims description 2
239000002254 cytotoxic agent Substances 0.000 claims description 2
208000021302 gastroesophageal reflux disease Diseases 0.000 claims description 2
210000002429 large intestine Anatomy 0.000 claims description 2
201000001119 neuropathy Diseases 0.000 claims description 2
230000007823 neuropathy Effects 0.000 claims description 2
230000008855 peristalsis Effects 0.000 claims description 2
230000002980 postoperative effect Effects 0.000 claims description 2
230000001107 psychogenic effect Effects 0.000 claims description 2
230000005855 radiation Effects 0.000 claims description 2
230000009467 reduction Effects 0.000 claims description 2
206010037211 Psychomotor hyperactivity Diseases 0.000 claims 1
210000000653 nervous system Anatomy 0.000 claims 1
230000002018 overexpression Effects 0.000 claims 1
230000003248 secreting effect Effects 0.000 claims 1
210000004027 cell Anatomy 0.000 description 93
108090000623 proteins and genes Proteins 0.000 description 65
235000018102 proteins Nutrition 0.000 description 59
102000004169 proteins and genes Human genes 0.000 description 59
239000013615 primer Substances 0.000 description 56
210000001519 tissue Anatomy 0.000 description 52
102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 47
108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 47
239000012634 fragment Substances 0.000 description 39
241001465754 Metazoa Species 0.000 description 32
229930012538 Paclitaxel Natural products 0.000 description 32
229960001592 paclitaxel Drugs 0.000 description 32
239000000523 sample Substances 0.000 description 32
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 32
102000001839 Neurturin Human genes 0.000 description 31
108010015406 Neurturin Proteins 0.000 description 31
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 31
102100036660 Persephin Human genes 0.000 description 29
238000006243 chemical reaction Methods 0.000 description 29
108020004999 messenger RNA Proteins 0.000 description 29
108010025020 Nerve Growth Factor Proteins 0.000 description 28
108010070453 persephin Proteins 0.000 description 28
238000002474 experimental method Methods 0.000 description 24
241000700159 Rattus Species 0.000 description 21
239000011780 sodium chloride Substances 0.000 description 21
239000003900 neurotrophic factor Substances 0.000 description 20
108091032973 (ribonucleotides)n+m Proteins 0.000 description 19
238000012360 testing method Methods 0.000 description 19
102000005962 receptors Human genes 0.000 description 18
108020003175 receptors Proteins 0.000 description 18
239000000872 buffer Substances 0.000 description 17
238000010367 cloning Methods 0.000 description 17
125000003729 nucleotide group Chemical group 0.000 description 17
235000001014 amino acid Nutrition 0.000 description 16
238000003556 assay Methods 0.000 description 16
125000000539 amino acid group Chemical group 0.000 description 14
238000002347 injection Methods 0.000 description 14
239000007924 injection Substances 0.000 description 14
230000004083 survival effect Effects 0.000 description 14
238000002509 fluorescent in situ hybridization Methods 0.000 description 13
239000000203 mixture Substances 0.000 description 13
239000002773 nucleotide Substances 0.000 description 13
239000002953 phosphate buffered saline Substances 0.000 description 13
239000000047 product Substances 0.000 description 13
150000001413 amino acids Chemical class 0.000 description 12
230000001186 cumulative effect Effects 0.000 description 12
210000002569 neuron Anatomy 0.000 description 12
230000009257 reactivity Effects 0.000 description 12
239000003981 vehicle Substances 0.000 description 12
108091026890 Coding region Proteins 0.000 description 11
102000007072 Nerve Growth Factors Human genes 0.000 description 11
238000012408 PCR amplification Methods 0.000 description 11
208000024891 symptom Diseases 0.000 description 11
108020004705 Codon Proteins 0.000 description 10
238000012300 Sequence Analysis Methods 0.000 description 10
239000002609 medium Substances 0.000 description 10
238000004458 analytical method Methods 0.000 description 9
210000000349 chromosome Anatomy 0.000 description 9
238000003776 cleavage reaction Methods 0.000 description 9
230000007017 scission Effects 0.000 description 9
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 8
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
108020005067 RNA Splice Sites Proteins 0.000 description 8
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 8
229960000723 ampicillin Drugs 0.000 description 8
210000001638 cerebellum Anatomy 0.000 description 8
230000006735 deficit Effects 0.000 description 8
210000005153 frontal cortex Anatomy 0.000 description 8
238000005259 measurement Methods 0.000 description 8
238000013519 translation Methods 0.000 description 8
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 8
102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 7
206010040030 Sensory loss Diseases 0.000 description 7
230000003321 amplification Effects 0.000 description 7
230000008901 benefit Effects 0.000 description 7
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 7
HKSZLNNOFSGOKW-UHFFFAOYSA-N ent-staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 HKSZLNNOFSGOKW-UHFFFAOYSA-N 0.000 description 7
230000001605 fetal effect Effects 0.000 description 7
239000000499 gel Substances 0.000 description 7
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 7
239000003446 ligand Substances 0.000 description 7
238000003199 nucleic acid amplification method Methods 0.000 description 7
210000002307 prostate Anatomy 0.000 description 7
HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 description 7
CGPUWJWCVCFERF-UHFFFAOYSA-N staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(OC)O1 CGPUWJWCVCFERF-UHFFFAOYSA-N 0.000 description 7
CJLHTKGWEUGORV-UHFFFAOYSA-N Artemin Chemical compound C1CC2(C)C(O)CCC(=C)C2(O)C2C1C(C)C(=O)O2 CJLHTKGWEUGORV-UHFFFAOYSA-N 0.000 description 6
108091060211 Expressed sequence tag Proteins 0.000 description 6
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
102000015336 Nerve Growth Factor Human genes 0.000 description 6
108091034117 Oligonucleotide Proteins 0.000 description 6
108700026244 Open Reading Frames Proteins 0.000 description 6
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
239000011543 agarose gel Substances 0.000 description 6
230000006907 apoptotic process Effects 0.000 description 6
230000001351 cycling effect Effects 0.000 description 6
210000000548 hind-foot Anatomy 0.000 description 6
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
238000001727 in vivo Methods 0.000 description 6
210000004072 lung Anatomy 0.000 description 6
210000002241 neurite Anatomy 0.000 description 6
239000011535 reaction buffer Substances 0.000 description 6
238000003757 reverse transcription PCR Methods 0.000 description 6
230000001953 sensory effect Effects 0.000 description 6
210000002966 serum Anatomy 0.000 description 6
238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
108020005544 Antisense RNA Proteins 0.000 description 5
108091035707 Consensus sequence Proteins 0.000 description 5
102000004190 Enzymes Human genes 0.000 description 5
108090000790 Enzymes Proteins 0.000 description 5
102100039556 Galectin-4 Human genes 0.000 description 5
206010029260 Neuroblastoma Diseases 0.000 description 5
108091081024 Start codon Proteins 0.000 description 5
239000008049 TAE buffer Substances 0.000 description 5
HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 5
230000003213 activating effect Effects 0.000 description 5
210000004556 brain Anatomy 0.000 description 5
-1 cDNA Chemical class 0.000 description 5
239000003184 complementary RNA Substances 0.000 description 5
238000001514 detection method Methods 0.000 description 5
238000005516 engineering process Methods 0.000 description 5
229940088598 enzyme Drugs 0.000 description 5
230000006870 function Effects 0.000 description 5
230000004927 fusion Effects 0.000 description 5
210000001320 hippocampus Anatomy 0.000 description 5
238000009396 hybridization Methods 0.000 description 5
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 5
238000013507 mapping Methods 0.000 description 5
230000002441 reversible effect Effects 0.000 description 5
159000000000 sodium salts Chemical class 0.000 description 5
239000000243 solution Substances 0.000 description 5
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 4
230000004568 DNA-binding Effects 0.000 description 4
239000007995 HEPES buffer Substances 0.000 description 4
241000282412 Homo Species 0.000 description 4
101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 4
238000000636 Northern blotting Methods 0.000 description 4
108010076504 Protein Sorting Signals Proteins 0.000 description 4
238000012181 QIAquick gel extraction kit Methods 0.000 description 4
108091034057 RNA (poly(A)) Proteins 0.000 description 4
108010006785 Taq Polymerase Proteins 0.000 description 4
108091023040 Transcription factor Proteins 0.000 description 4
102000040945 Transcription factor Human genes 0.000 description 4
230000004071 biological effect Effects 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
210000003169 central nervous system Anatomy 0.000 description 4
238000010494 dissociation reaction Methods 0.000 description 4
230000005593 dissociations Effects 0.000 description 4
230000028436 dopamine uptake Effects 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
210000003734 kidney Anatomy 0.000 description 4
239000012528 membrane Substances 0.000 description 4
210000001428 peripheral nervous system Anatomy 0.000 description 4
238000000746 purification Methods 0.000 description 4
230000011514 reflex Effects 0.000 description 4
230000001105 regulatory effect Effects 0.000 description 4
230000000638 stimulation Effects 0.000 description 4
238000013518 transcription Methods 0.000 description 4
230000035897 transcription Effects 0.000 description 4
PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 4
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
101710205806 Artemin Proteins 0.000 description 3
108020004635 Complementary DNA Proteins 0.000 description 3
239000003155 DNA primer Substances 0.000 description 3
230000006820 DNA synthesis Effects 0.000 description 3
102000016911 Deoxyribonucleases Human genes 0.000 description 3
108010053770 Deoxyribonucleases Proteins 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
101000997829 Homo sapiens Glial cell line-derived neurotrophic factor Proteins 0.000 description 3
108091092195 Intron Proteins 0.000 description 3
230000004988 N-glycosylation Effects 0.000 description 3
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 3
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 3
108700008625 Reporter Genes Proteins 0.000 description 3
240000004808 Saccharomyces cerevisiae Species 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
108010009583 Transforming Growth Factors Proteins 0.000 description 3
102000009618 Transforming Growth Factors Human genes 0.000 description 3
108090000631 Trypsin Proteins 0.000 description 3
102000004142 Trypsin Human genes 0.000 description 3
244000309466 calf Species 0.000 description 3
229940041514 candida albicans extract Drugs 0.000 description 3
239000004202 carbamide Substances 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
210000001612 chondrocyte Anatomy 0.000 description 3
230000002759 chromosomal effect Effects 0.000 description 3
210000001072 colon Anatomy 0.000 description 3
238000010276 construction Methods 0.000 description 3
238000013461 design Methods 0.000 description 3
238000011161 development Methods 0.000 description 3
230000029087 digestion Effects 0.000 description 3
238000009826 distribution Methods 0.000 description 3
210000003754 fetus Anatomy 0.000 description 3
229930182830 galactose Natural products 0.000 description 3
239000008103 glucose Substances 0.000 description 3
229930004094 glycosylphosphatidylinositol Natural products 0.000 description 3
210000002216 heart Anatomy 0.000 description 3
230000001976 improved effect Effects 0.000 description 3
230000003993 interaction Effects 0.000 description 3
238000007913 intrathecal administration Methods 0.000 description 3
210000004185 liver Anatomy 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
210000001259 mesencephalon Anatomy 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
208000015122 neurodegenerative disease Diseases 0.000 description 3
230000000324 neuroprotective effect Effects 0.000 description 3
210000001672 ovary Anatomy 0.000 description 3
210000000496 pancreas Anatomy 0.000 description 3
230000037361 pathway Effects 0.000 description 3
239000008188 pellet Substances 0.000 description 3
210000002826 placenta Anatomy 0.000 description 3
238000012545 processing Methods 0.000 description 3
230000001737 promoting effect Effects 0.000 description 3
238000012216 screening Methods 0.000 description 3
238000012163 sequencing technique Methods 0.000 description 3
239000007787 solid Substances 0.000 description 3
230000009466 transformation Effects 0.000 description 3
239000012588 trypsin Substances 0.000 description 3
239000012137 tryptone Substances 0.000 description 3
210000004885 white matter Anatomy 0.000 description 3
239000012138 yeast extract Substances 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
208000011231 Crohn disease Diseases 0.000 description 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
206010052804 Drug tolerance Diseases 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
108700039887 Essential Genes Proteins 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
108090001126 Furin Proteins 0.000 description 2
102000004961 Furin Human genes 0.000 description 2
241000287828 Gallus gallus Species 0.000 description 2
101001108441 Homo sapiens Neurturin Proteins 0.000 description 2
101001136670 Homo sapiens Persephin Proteins 0.000 description 2
208000023105 Huntington disease Diseases 0.000 description 2
101150111783 NTRK1 gene Proteins 0.000 description 2
101150117329 NTRK3 gene Proteins 0.000 description 2
102000007339 Nerve Growth Factor Receptors Human genes 0.000 description 2
101150056950 Ntrk2 gene Proteins 0.000 description 2
238000009004 PCR Kit Methods 0.000 description 2
239000013614 RNA sample Substances 0.000 description 2
108091005682 Receptor kinases Proteins 0.000 description 2
102000006382 Ribonucleases Human genes 0.000 description 2
108010083644 Ribonucleases Proteins 0.000 description 2
208000034189 Sclerosis Diseases 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
101001095983 Staphylococcus aureus Protein rep Proteins 0.000 description 2
102000007238 Transferrin Receptors Human genes 0.000 description 2
108010033576 Transferrin Receptors Proteins 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
238000000540 analysis of variance Methods 0.000 description 2
108091008324 binding proteins Proteins 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
239000007975 buffered saline Substances 0.000 description 2
238000010804 cDNA synthesis Methods 0.000 description 2
239000011575 calcium Substances 0.000 description 2
210000005056 cell body Anatomy 0.000 description 2
239000013592 cell lysate Substances 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
210000001175 cerebrospinal fluid Anatomy 0.000 description 2
230000035605 chemotaxis Effects 0.000 description 2
230000014107 chromosome localization Effects 0.000 description 2
ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
230000007423 decrease Effects 0.000 description 2
229960000935 dehydrated alcohol Drugs 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
238000010586 diagram Methods 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
210000005064 dopaminergic neuron Anatomy 0.000 description 2
230000004064 dysfunction Effects 0.000 description 2
230000002900 effect on cell Effects 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
229960004756 ethanol Drugs 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
239000013613 expression plasmid Substances 0.000 description 2
235000013305 food Nutrition 0.000 description 2
210000002683 foot Anatomy 0.000 description 2
108020001507 fusion proteins Proteins 0.000 description 2
102000037865 fusion proteins Human genes 0.000 description 2
230000007160 gastrointestinal dysfunction Effects 0.000 description 2
210000001035 gastrointestinal tract Anatomy 0.000 description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
239000010931 gold Substances 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
230000026781 habituation Effects 0.000 description 2
102000052654 human GDNF Human genes 0.000 description 2
210000005260 human cell Anatomy 0.000 description 2
210000003917 human chromosome Anatomy 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
210000003000 inclusion body Anatomy 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
238000001802 infusion Methods 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
210000000936 intestine Anatomy 0.000 description 2
238000002372 labelling Methods 0.000 description 2
239000007788 liquid Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
230000004060 metabolic process Effects 0.000 description 2
230000000394 mitotic effect Effects 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
230000004899 motility Effects 0.000 description 2
210000002161 motor neuron Anatomy 0.000 description 2
230000035772 mutation Effects 0.000 description 2
210000005036 nerve Anatomy 0.000 description 2
230000000626 neurodegenerative effect Effects 0.000 description 2
230000014511 neuron projection development Effects 0.000 description 2
230000009223 neuronal apoptosis Effects 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
239000013600 plasmid vector Substances 0.000 description 2
239000008389 polyethoxylated castor oil Substances 0.000 description 2
238000003752 polymerase chain reaction Methods 0.000 description 2
108091033319 polynucleotide Proteins 0.000 description 2
102000040430 polynucleotide Human genes 0.000 description 2
239000013641 positive control Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
230000004224 protection Effects 0.000 description 2
KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
238000003908 quality control method Methods 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
239000012679 serum free medium Substances 0.000 description 2
210000002027 skeletal muscle Anatomy 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000000527 sonication Methods 0.000 description 2
230000009870 specific binding Effects 0.000 description 2
238000013222 sprague-dawley male rat Methods 0.000 description 2
238000007619 statistical method Methods 0.000 description 2
239000008223 sterile water Substances 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
230000002889 sympathetic effect Effects 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
230000005026 transcription initiation Effects 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
230000008673 vomiting Effects 0.000 description 2
238000005303 weighing Methods 0.000 description 2
UGYPXRGQGNLWOF-UHFFFAOYSA-N 1-(ethyliminomethylideneamino)-n,n-dimethylpropan-1-amine Chemical compound CCN=C=NC(CC)N(C)C UGYPXRGQGNLWOF-UHFFFAOYSA-N 0.000 description 1
108020004463 18S ribosomal RNA Proteins 0.000 description 1
FMYBFLOWKQRBST-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]acetic acid;nickel Chemical compound [Ni].OC(=O)CN(CC(O)=O)CC(O)=O FMYBFLOWKQRBST-UHFFFAOYSA-N 0.000 description 1
PMUNIMVZCACZBB-UHFFFAOYSA-N 2-hydroxyethylazanium;chloride Chemical compound Cl.NCCO PMUNIMVZCACZBB-UHFFFAOYSA-N 0.000 description 1
108020005096 28S Ribosomal RNA Proteins 0.000 description 1
CFWHDFIMMOKKPM-UHFFFAOYSA-N 3,10-dimethoxypentacyclo[10.2.1.15,8.02,11.04,9]hexadeca-2,4(9),10-triene Chemical compound C12=C(OC)C=3C(C4)CCC4C=3C(OC)=C2C2CC1CC2 CFWHDFIMMOKKPM-UHFFFAOYSA-N 0.000 description 1
COYZTUXPHRHKGV-UHFFFAOYSA-N 4-methoxy-5-[3-(2-methoxy-4-nitro-5-sulfophenyl)-5-(phenylcarbamoyl)-1h-tetrazol-2-yl]-2-nitrobenzenesulfonic acid Chemical compound COC1=CC([N+]([O-])=O)=C(S(O)(=O)=O)C=C1N1N(C=2C(=CC(=C(C=2)S(O)(=O)=O)[N+]([O-])=O)OC)N=C(C(=O)NC=2C=CC=CC=2)N1 COYZTUXPHRHKGV-UHFFFAOYSA-N 0.000 description 1
WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 1
208000004998 Abdominal Pain Diseases 0.000 description 1
206010000060 Abdominal distension Diseases 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
240000006108 Allium ampeloprasum Species 0.000 description 1
235000005254 Allium ampeloprasum Nutrition 0.000 description 1
241000269627 Amphiuma means Species 0.000 description 1
108090000672 Annexin A5 Proteins 0.000 description 1
102000004121 Annexin A5 Human genes 0.000 description 1
108020004491 Antisense DNA Proteins 0.000 description 1
102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
206010003011 Appendicitis Diseases 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
206010009900 Colitis ulcerative Diseases 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
238000009007 Diagnostic Kit Methods 0.000 description 1
206010012742 Diarrhoea infectious Diseases 0.000 description 1
201000003066 Diffuse Scleroderma Diseases 0.000 description 1
VYFYYTLLBUKUHU-UHFFFAOYSA-N Dopamine Natural products NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 1
101150089383 EVN gene Proteins 0.000 description 1
206010059186 Early satiety Diseases 0.000 description 1
108700024394 Exon Proteins 0.000 description 1
108091006020 Fc-tagged proteins Proteins 0.000 description 1
102000020897 Formins Human genes 0.000 description 1
108091022623 Formins Proteins 0.000 description 1
108010001515 Galectin 4 Proteins 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
102000004216 Glial cell line-derived neurotrophic factor receptors Human genes 0.000 description 1
108090000722 Glial cell line-derived neurotrophic factor receptors Proteins 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 1
101000899095 Homo sapiens BPI fold-containing family A member 2 Proteins 0.000 description 1
101100281953 Homo sapiens GAPDH gene Proteins 0.000 description 1
101000950669 Homo sapiens Mitogen-activated protein kinase 9 Proteins 0.000 description 1
101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 1
101000638044 Homo sapiens Neurogenic differentiation factor 1 Proteins 0.000 description 1
101000615965 Homo sapiens Phosphoserine phosphatase Proteins 0.000 description 1
101000766306 Homo sapiens Serotransferrin Proteins 0.000 description 1
206010020852 Hypertonia Diseases 0.000 description 1
206010062767 Hypophysitis Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
208000022559 Inflammatory bowel disease Diseases 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
102100037852 Insulin-like growth factor I Human genes 0.000 description 1
102100034343 Integrase Human genes 0.000 description 1
208000034800 Leukoencephalopathies Diseases 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
208000002720 Malnutrition Diseases 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
102100040243 Microtubule-associated protein tau Human genes 0.000 description 1
102100037809 Mitogen-activated protein kinase 9 Human genes 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
206010068871 Myotonic dystrophy Diseases 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
108091008604 NGF receptors Proteins 0.000 description 1
206010028813 Nausea Diseases 0.000 description 1
108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 1
102100032063 Neurogenic differentiation factor 1 Human genes 0.000 description 1
206010029350 Neurotoxicity Diseases 0.000 description 1
102000016978 Orphan receptors Human genes 0.000 description 1
108070000031 Orphan receptors Proteins 0.000 description 1
102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 1
101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 1
206010033963 Parathyroid tumour Diseases 0.000 description 1
DPWPWRLQFGFJFI-UHFFFAOYSA-N Pargyline Chemical compound C#CCN(C)CC1=CC=CC=C1 DPWPWRLQFGFJFI-UHFFFAOYSA-N 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
239000004365 Protease Substances 0.000 description 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
108700020978 Proto-Oncogene Proteins 0.000 description 1
102000052575 Proto-Oncogene Human genes 0.000 description 1
239000005700 Putrescine Substances 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
238000010240 RT-PCR analysis Methods 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
201000003604 Renal agenesis Diseases 0.000 description 1
206010064655 Renal aplasia Diseases 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
201000009594 Systemic Scleroderma Diseases 0.000 description 1
206010042953 Systemic sclerosis Diseases 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
206010044221 Toxic encephalopathy Diseases 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
201000006704 Ulcerative Colitis Diseases 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
241000700605 Viruses Species 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
239000008351 acetate buffer Substances 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000012190 activator Substances 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000008272 agar Substances 0.000 description 1
239000005030 aluminium foil Substances 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
238000010171 animal model Methods 0.000 description 1
238000005349 anion exchange Methods 0.000 description 1
208000022531 anorexia Diseases 0.000 description 1
230000003042 antagnostic effect Effects 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
230000003474 anti-emetic effect Effects 0.000 description 1
229940125683 antiemetic agent Drugs 0.000 description 1
239000002111 antiemetic agent Substances 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
239000003816 antisense DNA Substances 0.000 description 1
230000036528 appetite Effects 0.000 description 1
235000019789 appetite Nutrition 0.000 description 1
210000001188 articular cartilage Anatomy 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
238000005452 bending Methods 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
208000024330 bloating Diseases 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
208000014581 breast ductal adenocarcinoma Diseases 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
229910002091 carbon monoxide Inorganic materials 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
230000030833 cell death Effects 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
230000007541 cellular toxicity Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000003392 chemiluminescence resonance energy transfer Methods 0.000 description 1
230000003399 chemotactic effect Effects 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
229960003920 cocaine Drugs 0.000 description 1
208000027742 colicky pain Diseases 0.000 description 1
239000003636 conditioned culture medium Substances 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
230000034994 death Effects 0.000 description 1
206010061428 decreased appetite Diseases 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
235000019262 disodium citrate Nutrition 0.000 description 1
239000002526 disodium citrate Substances 0.000 description 1
BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
229960003638 dopamine Drugs 0.000 description 1
210000004002 dopaminergic cell Anatomy 0.000 description 1
230000003291 dopaminomimetic effect Effects 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000000975 dye Substances 0.000 description 1
230000000431 effect on proliferation Effects 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
229940073579 ethanolamine hydrochloride Drugs 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
210000002458 fetal heart Anatomy 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
230000037433 frameshift Effects 0.000 description 1
235000019525 fullness Nutrition 0.000 description 1
238000002825 functional assay Methods 0.000 description 1
230000005176 gastrointestinal motility Effects 0.000 description 1
238000003209 gene knockout Methods 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
230000010243 gut motility Effects 0.000 description 1
102000052667 human NRTN Human genes 0.000 description 1
102000043827 human Smooth muscle Human genes 0.000 description 1
108700038605 human Smooth muscle Proteins 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000036512 infertility Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
208000003243 intestinal obstruction Diseases 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
230000031146 intracellular signal transduction Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
229940043355 kinase inhibitor Drugs 0.000 description 1
238000011813 knockout mouse model Methods 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
238000011068 loading method Methods 0.000 description 1
201000005296 lung carcinoma Diseases 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
235000000824 malnutrition Nutrition 0.000 description 1
230000001071 malnutrition Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000002438 mitochondrial effect Effects 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
HZAXFHJVJLSVMW-UHFFFAOYSA-N monoethanolamine hydrochloride Natural products NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
230000004660 morphological change Effects 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
230000008693 nausea Effects 0.000 description 1
230000009826 neoplastic cell growth Effects 0.000 description 1
238000007857 nested PCR Methods 0.000 description 1
230000004770 neurodegeneration Effects 0.000 description 1
230000007472 neurodevelopment Effects 0.000 description 1
230000004031 neuronal differentiation Effects 0.000 description 1
230000004112 neuroprotection Effects 0.000 description 1
230000003018 neuroregenerative effect Effects 0.000 description 1
230000007135 neurotoxicity Effects 0.000 description 1
231100000228 neurotoxicity Toxicity 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
208000015380 nutritional deficiency disease Diseases 0.000 description 1
238000002966 oligonucleotide array Methods 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000000963 osteoblast Anatomy 0.000 description 1
229960001779 pargyline Drugs 0.000 description 1
230000035515 penetration Effects 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
208000027232 peripheral nervous system disease Diseases 0.000 description 1
230000003285 pharmacodynamic effect Effects 0.000 description 1
208000028591 pheochromocytoma Diseases 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
210000003635 pituitary gland Anatomy 0.000 description 1
238000007747 plating Methods 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
102000054765 polymorphisms of proteins Human genes 0.000 description 1
239000002157 polynucleotide Substances 0.000 description 1
108010055896 polyornithine Proteins 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
229940124606 potential therapeutic agent Drugs 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
238000011533 pre-incubation Methods 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
239000002987 primer (paints) Substances 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
239000003909 protein kinase inhibitor Substances 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
239000012264 purified product Substances 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000010791 quenching Methods 0.000 description 1
238000003259 recombinant expression Methods 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
238000004153 renaturation Methods 0.000 description 1
BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
201000009881 secretory diarrhea Diseases 0.000 description 1
210000000413 sensory ganglia Anatomy 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
210000000329 smooth muscle myocyte Anatomy 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
229960001471 sodium selenite Drugs 0.000 description 1
235000015921 sodium selenite Nutrition 0.000 description 1
239000011781 sodium selenite Substances 0.000 description 1
239000007909 solid dosage form Substances 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
108010068698 spleen exonuclease Proteins 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000037351 starvation Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
210000003523 substantia nigra Anatomy 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
210000000331 sympathetic ganglia Anatomy 0.000 description 1
230000001360 synchronised effect Effects 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
210000001550 testis Anatomy 0.000 description 1
125000003831 tetrazolyl group Chemical group 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
210000003437 trachea Anatomy 0.000 description 1
108091006106 transcriptional activators Proteins 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
208000017997 tumor of parathyroid gland Diseases 0.000 description 1
208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
210000003606 umbilical vein Anatomy 0.000 description 1
238000003026 viability measurement method Methods 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1